| Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy A El‐Shamy, M Nagano‐Fujii, N Sasase, S Imoto, SR Kim, H Hotta Hepatology 48 (1), 38-47, 2008 | 163 | 2008 |
| Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview A El-Shamy, H Hotta World Journal of Gastroenterology: WJG 20 (24), 7555, 2014 | 64 | 2014 |
| Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti‐NS5A antibodies in pre … A El‐Shamy, M Sasayama, M Nagano‐Fujii, N Sasase, S Imoto, SR Kim, ... Microbiology and immunology 51 (4), 471-482, 2007 | 55 | 2007 |
| Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma A El‐Shamy, M Shindo, I Shoji, L Deng, T Okuno, H Hotta Hepatology 58 (2), 555-563, 2013 | 40 | 2013 |
| The correlation between hepatitis B virus precore/core mutations and the progression of severe liver disease AA Al-Qahtani, MR Al-Anazi, N Nazir, AA Abdo, FM Sanai, ... Frontiers in cellular and infection microbiology 8, 355, 2018 | 36 | 2018 |
| Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy A El-Shamy, SR Kim, YH Ide, N Sasase, S Imoto, L Deng, I Shoji, H Hotta Intervirology 55 (1), 1-11, 2011 | 33 | 2011 |
| Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy A El-Shamy, I Shoji, SR Kim, Y Ide, S Imoto, L Deng, S Yoon, T Fujisawa, ... PLoS One 7 (2), e30513, 2012 | 31 | 2012 |
| CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway Y Saiman, R Agarwal, DSA Hickman, M Fausther, A El-Shamy, JA Dranoff, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 305 (5 …, 2013 | 29 | 2013 |
| NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon–ribavirin therapy in Egyptian patients A El-Shamy, I Shoji, W El-Akel, SE Bilasy, L Deng, M El-Raziky, D Jiang, ... Journal of clinical microbiology 50 (12), 3886-3892, 2012 | 29 | 2012 |
| Detection of risky esophageal varices by two-dimensional ultrasound: when to perform endoscopy H Mahfouz, M Fakhry, M Afifi, M Nafady, K Amer, A El-shamy, U Kenji, ... The American Journal of the Medical Sciences 347 (1), 28-33, 2014 | 28 | 2014 |
| Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated‐interferon/ribavirin combination therapy A El‐Shamy, I Shoji, T Saito, H Watanabe, YH Ide, L Deng, S Kawata, ... Microbiology and immunology 55 (6), 418-426, 2011 | 28 | 2011 |
| The complement system and C1q in chronic hepatitis C virus infection and mixed cryoglobulinemia A El-Shamy, AD Branch, TD Schiano, PD Gorevic Frontiers in immunology 9, 1001, 2018 | 25 | 2018 |
| A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene A El-Shamy, FJ Eng, EH Doyle, AL Klepper, X Sun, A Sangiovanni, ... Journal of hepatology 63 (6), 1323-1333, 2015 | 25 | 2015 |
| Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency H Ho, L Radigan, G Bongers, A El-Shamy, C Cunningham-Rundles JCI insight 6 (19), 2021 | 24 | 2021 |
| Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load SR Kim, A El-Shamy, S Imoto, KI Kim, Y Ide, L Deng, I Shoji, Y Tanaka, ... Journal of gastroenterology 47, 1143-1151, 2012 | 24 | 2012 |
| Anomaly detection and bottleneck identification of the distributed application in cloud data center using software–defined networking AM El-Shamy, NA El-Fishawy, G Attiya, MAA Mohamed Egyptian informatics journal 22 (4), 417-432, 2021 | 20 | 2021 |
| Mortality prediction of nonalcoholic patients presenting with upper gastrointestinal bleeding using data mining MA Abd Elrazek, HM Mahfouz, AM Metwally, AM El-Shamy European Journal of Gastroenterology & Hepatology 26 (2), 187-191, 2014 | 20 | 2014 |
| Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients A El-Shamy, M Pendleton, FJ Eng, EH Doyle, A Bashir, AD Branch Scientific Reports 6 (1), 27025, 2016 | 18 | 2016 |
| Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infection EH Doyle, A Rahman, C Aloman, AL Klepper, A El-Shamy, F Eng, ... PLoS Pathogens 15 (7), e1007935, 2019 | 16 | 2019 |
| Hepatitis C virus double‐stranded RNA is the predominant form in human liver and in interferon‐treated cells A Klepper, FJ Eng, EH Doyle, A El‐Shamy, AH Rahman, MI Fiel, ... Hepatology 66 (2), 357-370, 2017 | 16 | 2017 |
